Board update

By

Regulatory News | 19 Apr, 2021

Updated : 07:00

RNS Number : 8087V
Anpario PLC
19 April 2021
 

Anpario plc

("Anpario" or the "Company")

 

Board update

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity advises that, as previously announced, Peter Lawrence will retire as Non-Executive Chairman at the AGM and will leave the Group on 17th June 2021 and we are delighted that Kate Allum will take over as Non-Executive Chairman from that date.

 

Also, Matthew Robinson takes over with immediate effect as Senior Independent Director from Richard Wood who retired from the Board on 31 March 2021.

 

Both Kate and Matthew were recently appointed as Non-Executive Directors of Anpario and bring considerable senior executive and Non-Executive experience of publicly listed companies.

 

We also announce the appointments of chair to the following key committees with immediate effect:

 

Audit Committee Chairman                                             Matthew Robinson

Remuneration Committee Chairman                                Matthew Robinson

Nomination Committee Chairman                                    Ian Hamilton

 

Peter Lawrence, Chairman, stated:

 

"We are pleased to announce these appointments which concludes our current Board succession plan and demonstrates our commitment to strong corporate governance.  I look forward with confidence to handing over to Kate in June."

 

 

Anpario plc


Richard Edwards, CEO

+44(0) 777 6417 129

Karen Prior, Group Finance Director

+44(0) 1909 537380



Peel Hunt LLP (NOMAD)

+44 (0)20 7418 8900

Adrian Trimmings


Andrew Clark


Will Bell


 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFWESAEFSESL

Last news